Giovanni Caforio

Novartis names ex-BMS CEO Caforio as chair amid strong Q1
Pharmaphorum
Tue, 04/23/24 - 10:29 am
Novartis
earnings
Giovanni Caforio
Bristol Myers Squibb
Bristol Myers CEO Caforio steps down
Yahoo/Reuters
Wed, 04/26/23 - 05:55 pm
Bristol Myers Squibb
Pharma CEOs
Giovanni Caforio
Christopher Boerner
Even as Revlimid's star fades, Bristol Myers' core offerings have reached a 'critical mass,' CEO says
Fierce Pharma
Thu, 10/27/22 - 11:04 am
Bristol Myers Squibb
generics
Revlimid
Abecma
Breyanzi
Pharma CEOs
Giovanni Caforio
Bristol Myers Squibb CEO Caforio collected $20M in 2020 pay amid Celgene integration, pandemic challenges
Fierce Pharma
Fri, 03/26/21 - 10:37 am
Bristol-Myers Squibb
Giovanni Caforio
Pharma CEOs
executive pay
Bristol Myers to CEO Caforio: Good job on Celgene so far, but you'll have to work for your raise
Fierce Pharma
Thu, 04/2/20 - 12:00 am
Bristol-Myers Squibb
Celgene
executive pay
Giovanni Caforio
Bristol Myers CEO Caforio hires a top investment banker from Barclays for his next BD/strategy chief
Endpoints
Wed, 03/18/20 - 10:18 am
Bristol-Myers Squibb
M&A
Giovanni Caforio
JPM: Bristol chief says one-third of Celgene cost cuts will hit in 2020
Fierce Pharma
Mon, 01/13/20 - 11:43 pm
M&A
JPMHC 2020
Bristol-Myers Squibb
Celgene
Giovanni Caforio
Having gobbled up Celgene, the Bristol-Myers CEO ducks questions about his key rival
Stat
Fri, 11/22/19 - 10:00 am
Bristol-Myers Squibb
Celgene
Pharma CEOs
Giovanni Caforio
Merck
M&A
Bristol-Myers CEO Giovanni Caforio Named PhRMA Board Chairman
Xtalks
Thu, 09/5/19 - 08:28 pm
PhRMA
Giovanni Caforio
Bristol-Myers Squibb
Pharma CEOs
Bristol's Celgene buyout 'more important' given drug pricing pressure, CEO says
Fierce Pharma
Thu, 07/25/19 - 10:38 pm
Bristol-Myers Squibb
Celgene
M&A
drug pricing
Giovanni Caforio
Bristol-Myers CEO: We’re ‘one step closer to creating that great company’ with Celgene
CNBC
Sat, 04/13/19 - 12:03 pm
M&A
Bristol-Myers Squibb
Celgene
Pharma CEOs
Giovanni Caforio
After winning key support for Celgene buyout, Bristol-Myers CEO Caforio emerges as clear likely winner in looming shareholder vote
Endpoints
Sun, 03/31/19 - 03:47 pm
Bristol-Myers Squibb
Celgene
M&A
Starboard
Giovanni Caforio
Bristol-Myers CEO Caforio wants M&A dissidents to know there's been no 'high level' overtures about buying the company since '17
Endpoints
Tue, 03/12/19 - 07:35 pm
Bristol-Myers Squibb
Celgene
Giovanni Caforio
M&A
The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress
Stat
Thu, 02/21/19 - 12:41 pm
drug pricing
US Congress
Donald Trump
Richard Gonzalez
AbbVie
Ken Frazier
Merck
JNJ
Jennifer Taubert
Olivier Brandicourt
Sanofi
Pascal Soriot
AstraZeneca
Giovanni Caforio
Bristol-Myers Squibb
Albert Bourla
Pfizer
BMS CEO Giovanni Caforio Lays out Reasoning for $74 Billion Acquisition of Celgene
BioSpace
Sat, 01/5/19 - 03:08 pm
Bristol-Myers Squibb
M&A
Giovanni Caforio
Celgene
Bristol-Myers CEO Giovanni Caforio nets $18.7M in 2017 pay, a 10% raise
Fierce Pharma
Wed, 03/28/18 - 07:13 pm
Bristol-Myers Squibb
Pharma CEOs
Giovanni Caforio
executive pay
After 5 years, Eliquis' growth ceiling is nowhere in sight: Bristol-Myers CEO
Fierce Pharma
Thu, 01/11/18 - 09:48 am
Bristol-Myers Squibb
Eliquis
Pharma CEOs
Giovanni Caforio
Pfizer
JPMHC 2018
[video]Bristol-Myers Squibb CEO: Critical that treatments reach patients
Yahoo/CNBC
Wed, 06/7/17 - 10:11 am
patients
cancer
Bristol-Myers Squibb
drug pricing
ASCO 2017
Giovanni Caforio
Opdivo lung cancer slip took a bite out of Bristol CEO's bonus, but pay still hit $16.9M
Fierce Pharma
Thu, 04/13/17 - 11:50 am
Opdivo
Bristol-Myers Squibb
executive pay
Giovanni Caforio
Bristol-Myers Squibb: A New Chapter, and the Beginning of Sustained Growth
Motley Fool
Fri, 01/15/16 - 02:26 pm
Bristol-Myers Squibb
Giovanni Caforio

Pages